Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RSNA New Product Briefs: GE Healthcare, FujiFilm And Philips

This article was originally published in The Gray Sheet

Executive Summary

Some product highlights from the Radiological Society of North America annual meeting, which convened Dec. 1-6 in Chicago, include offerings from GE, FujiFilm and Philips.

You may also be interested in...



New Product Briefs

DexCom’s “professional” continuous glucose monitor, Cook launches Zilver PTX drug-eluting peripheral stent and more product news.

FDA, Congress Look To Nationalize Breast Density Reporting Requirements, Now In 13 States

FDA hopes to finish drafting a proposed rule by early next year requiring mammography screening professionals to notify women and their physicians of dense breast tissue that may warrant further imaging follow-up with MRI and ultrasound. Meanwhile, a bill was recently introduced in Congress on the same topic.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel